|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.95 GBX | -.--% |
|
+2.43% | -50.00% |
| 05-20 | London gets boost thanks to rate cut hopes | AN |
| 05-20 | ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant | AN |
ValiRx plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was GBP 0.0096 million. Net loss was GBP 2.04 million compared to GBP 2.37 million a year ago.
Basic loss per share from continuing operations was GBP 0.0201 compared to GBP 0.0306 a year ago. Diluted loss per share from continuing operations was GBP 0.0201 compared to GBP 0.0306 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -50.00% | 4.98M | |
| +11.91% | 114B | |
| +11.60% | 105B | |
| -4.68% | 23.83B | |
| -0.82% | 21.73B | |
| -10.12% | 18.1B | |
| -42.12% | 16.34B | |
| -17.47% | 16.13B | |
| +2.77% | 13.75B | |
| +34.58% | 11.76B |
VALIRX PLC 
